May 15, 2018 / 12:09 PM / 2 months ago

BRIEF-BioCanCell Reports Q1 Loss Per Share Of $0.13

May 15 (Reuters) - BioCanCell Ltd:

* BIOCANCELL REPORTS FIRST QUARTER 2018 FINANCIAL AND OPERATIONAL RESULTS AND PROVIDES CORPORATE UPDATE

* Q1 LOSS PER SHARE $0.13

* CASH AND CASH EQUIVALENTS WERE $0.67 MILLION AS OF MARCH 31, 2018 PRIOR TO RECEIVING PIPE FUNDING

* ANTICIPATES CASH AND CASH EQUIVALENTS WILL ENABLE IT TO FUND OPERATING EXPENSES, CAPITAL EXPENDITURE REQUIREMENTS INTO Q2 2019 Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below